Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system

被引:329
作者
Aryal, Muna [1 ,2 ]
Arvanitis, Costas D. [2 ]
Alexander, Phillip M. [2 ,3 ,4 ]
McDannold, Nathan [2 ]
机构
[1] Boston Coll, Dept Phys, Chestnut Hill, MA 02167 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA
[3] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX1 3PJ, England
[4] Univ Oxford, Brasenose Coll, Oxford OX1 3PJ, England
关键词
Brain; Drug delivery; Ultrasound; Microbubbles; GUIDED FOCUSED ULTRASOUND; CONVECTION-ENHANCED DELIVERY; LOW-FREQUENCY ULTRASOUND; NEUTRON-CAPTURE THERAPY; CONTRAST AGENT; TUMOR BARRIER; INTRAARTERIAL CHEMOTHERAPY; LIPOSOMAL DOXORUBICIN; RABBIT BRAIN; MOUSE-BRAIN;
D O I
10.1016/j.addr.2014.01.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physiology of the vasculature in the central nervous system (CNS), which includes the blood brain barrier (BBB) and other factors, complicates the delivery of most drugs to the brain. Different methods have been used to bypass the BBB, but they have limitations such as being invasive, non-targeted or requiring the formulation of new drugs. Focused ultrasound (FUS), when combined with circulating microbubbles, is a noninvasive method to locally and transiently disrupt the BBB at discrete targets. This review provides insight on the current status of this unique drug delivery technique, experience in preclinical models, and potential for clinical translation. If translated to humans, this method would offer a flexible means to target therapeutics to desired points or volumes in the brain, and enable the whole arsenal of drugs in the CNS that are currently prevented by the BBB. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 109
页数:16
相关论文
共 194 条
[1]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[2]   Transporting therapeutics across the blood-brain barrier [J].
Abbott, NJ ;
Romero, IA .
MOLECULAR MEDICINE TODAY, 1996, 2 (03) :106-113
[3]   Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors [J].
Alkins, Ryan ;
Burgess, Alison ;
Ganguly, Milan ;
Francia, Giulio ;
Kerbel, Robert ;
Wels, Winfried S. ;
Hynynen, Kullervo .
CANCER RESEARCH, 2013, 73 (06) :1892-1899
[4]   Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound [J].
Alkins, Ryan D. ;
Brodersen, Peter M. ;
Sodhi, Rana N. S. ;
Hynynen, Kullervo .
NEURO-ONCOLOGY, 2013, 15 (09) :1225-1235
[5]   NEURONS BUT NOT GLIAL CELLS OVEREXPRESS UBIQUITIN IN THE RAT BRAIN FOLLOWING FOCUSED ULTRASOUND-INDUCED OPENING OF THE BLOOD-BRAIN BARRIER [J].
Alonso, A. ;
Reinz, E. ;
Fatar, M. ;
Jenne, J. ;
Hennerici, M. G. ;
Meairs, S. .
NEUROSCIENCE, 2010, 169 (01) :116-124
[6]   Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening [J].
Alonso, Angelika ;
Reinz, Eileen ;
Leuchs, Barbara ;
Kleinschmidt, Juergen ;
Fatar, Marc ;
Geers, Bart ;
Lentacker, Ine ;
Hennerici, Michael G. ;
de Smedt, Stefaan C. ;
Meairs, Stephen .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 :e73
[7]   Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain [J].
Alonso, Angelika ;
Reinz, Eileen ;
Jenne, Juergen W. ;
Fatar, Marc ;
Schmidt-Glenewinkel, Hannah ;
Hennerici, Michael G. ;
Meairs, Stephen .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (07) :1394-1402
[8]   Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience [J].
Angelov, Lilyana ;
Doolittle, Nancy D. ;
Kraemer, Dale F. ;
Siegal, Tali ;
Barnett, Gene H. ;
Peereboom, David M. ;
Stevens, Glen ;
McGregor, John ;
Jahnke, Kristoph ;
Lacy, Cynthia A. ;
Hedrick, Nancy A. ;
Shalom, Edna ;
Ference, Sandra ;
Bell, Susan ;
Sorenson, Lisa ;
Tyson, Rose Marie ;
Haluska, Marianne ;
Neuwelt, Edward A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3503-3509
[9]  
[Anonymous], GLOB PUBLIC HEALTH
[10]  
APFEL RE, 1982, BRIT J CANCER, V45, P140